Türeci Ö - Search Results

1

Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial.

Gayed J, Bangad V, Xu X, Mensa F, Cutler M, Türeci Ö, Şahin U, Modjarrad K, Swanson KA, Anderson AS, Gurtman A, Kitchin N; C4591054 Study Group. Gayed J, et al. Among authors: tureci o. Vaccines (Basel). 2024 Jul 2;12(7):734. doi: 10.3390/vaccines12070734. Vaccines (Basel). 2024. PMID: 39066372 Free PMC article.

2

Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer.

Koslowski M, Türeci O, Bell C, Krause P, Lehr HA, Brunner J, Seitz G, Nestle FO, Huber C, Sahin U. Koslowski M, et al. Among authors: tureci o. Cancer Res. 2002 Nov 15;62(22):6750-5. Cancer Res. 2002. PMID: 12438276

3

Identification of tumor-associated autoantigens with SEREX.

Türeci O, Usener D, Schneider S, Sahin U. Türeci O, et al. Methods Mol Med. 2005;109:137-54. doi: 10.1385/1-59259-862-5:137. Methods Mol Med. 2005. PMID: 15585919

4

The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexes.

Koslowski M, Sahin U, Huber C, Türeci O. Koslowski M, et al. Among authors: tureci o. Hum Mol Genet. 2006 Aug 1;15(15):2392-9. doi: 10.1093/hmg/ddl163. Epub 2006 Jun 29. Hum Mol Genet. 2006. PMID: 16809397

5

Identification of new claudin family members by a novel PSI-BLAST based approach with enhanced specificity.

Wu J, Helftenbein G, Koslowski M, Sahin U, Tureci O. Wu J, et al. Among authors: tureci o. Proteins. 2006 Dec 1;65(4):808-15. doi: 10.1002/prot.21218. Proteins. 2006. PMID: 17022085

6

A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes.

Koslowski M, Sahin U, Mitnacht-Kraus R, Seitz G, Huber C, Türeci O. Koslowski M, et al. Among authors: tureci o. Cancer Res. 2007 Oct 1;67(19):9528-34. doi: 10.1158/0008-5472.CAN-07-1350. Cancer Res. 2007. PMID: 17909063

7

In silico strategy for detection of target candidates for antibody therapy of solid tumors.

Helftenbein G, Koslowski M, Dhaene K, Seitz G, Sahin U, Türeci O. Helftenbein G, et al. Among authors: tureci o. Gene. 2008 May 15;414(1-2):76-84. doi: 10.1016/j.gene.2008.02.009. Epub 2008 Feb 19. Gene. 2008. PMID: 18358640

8

MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes.

Koslowski M, Sahin U, Dhaene K, Huber C, Türeci O. Koslowski M, et al. Among authors: tureci o. Cancer Res. 2008 May 1;68(9):3458-66. doi: 10.1158/0008-5472.CAN-07-5768. Cancer Res. 2008. PMID: 18451174

9

Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2.

Koslowski M, Türeci O, Biesterfeld S, Seitz G, Huber C, Sahin U. Koslowski M, et al. Among authors: tureci o. J Biol Chem. 2009 Oct 16;284(42):28607-15. doi: 10.1074/jbc.M109.031120. Epub 2009 Aug 3. J Biol Chem. 2009. PMID: 19652226 Free PMC article.

10

Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2.

Koslowski M, Türeci O, Huber C, Sahin U. Koslowski M, et al. Among authors: tureci o. Mol Cancer. 2009 Sep 25;8:77. doi: 10.1186/1476-4598-8-77. Mol Cancer. 2009. PMID: 19781065 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters